Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma

H Auge1, C Yguel2, E Schmitt3

  • 1Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.

Case Reports in Hematology
|September 20, 2019
PubMed

Insights

This report details a rare case of acquired von Willebrand syndrome (VWS) linked to intracranial plasmacytoma. Effective treatment involved chemotherapy and stem cell transplant, leading to a positive patient outcome.

Area of Science:

  • Neurology
  • Hematology
  • Oncology

Background:

  • Intracranial plasmacytomas are rare central nervous system tumors.
  • Acquired von Willebrand syndrome (VWS) is an uncommon bleeding disorder.

Observation:

  • A patient presented with symptoms necessitating a stereotaxic intracerebral biopsy for plasmacytoma diagnosis.
  • Abnormal bleeding occurred post-biopsy during ventriculoperitoneal shunt placement.
  • Hemostasis assessment identified acquired von Willebrand disease.

Findings:

  • This is the first reported case of acquired VWS associated with intracranial plasmacytoma.
  • The patient achieved a very good partial response with no neurological symptoms after 4 months of maintenance therapy.
  • The patient remains progression-free 14 months post-presentation.

Implications:

  • Highlights a rare but significant association between intracranial plasmacytoma and acquired VWS.
  • Demonstrates the efficacy of a multi-modal treatment approach including VTD chemotherapy, stem cell transplantation, and maintenance therapy.
  • Suggests the importance of hemostasis assessment in patients with central nervous system tumors presenting with bleeding complications.